Compare companies
Chugai Pharmaceutical Co., Ltd. | Takeda Pharmaceutical Company Limited | HOYA Corporation | ||||
---|---|---|---|---|---|---|
Capitalization | ||||||
Price | 7036 | 4545 | 17760 | |||
Price priv. | ||||||
Number of shares, million | 1645.5 | 1580.34 | 352 | |||
Capitalization, billion | 6930 | 6830 | 5470 | |||
EBITDA, billion | 447.41 | 874.6 | 284.45 | |||
EV, billion | 8356.56 | 11284.15 | 6218.53 | |||
Profit and loss report | ||||||
Net profit, billion | 325.47 | 144.07 | 181.38 | |||
Revenue, billion | 1111.37 | 4263.76 | 762.61 | |||
EPS | 197.8 | 91.16 | 515.27 | |||
Balance | ||||||
Assets, billion | 1932.55 | 15108.79 | 1203.62 | |||
Debt, billion | 13.46 | 4843.75 | 29.24 | |||
Balance cost, billion | 1625.58 | 7273.26 | 967.76 | |||
Cash, billion | 458.67 | 457.8 | 525.16 | |||
Coefficients | ||||||
Dividend yield, % | 2.06 | 6.79 | 0.8511 | |||
Dividend | 98 | 192 | 110 | |||
Dividend yield priv., % | 0 | 0 | 0 | |||
Dividend priv. | 0 | 0 | 0 | |||
Dividends/profit, % | 40.43 | 199.34 | 21.38 | |||
P/S | 7.92 | 1.62 | 8.8 | |||
P/BV | 5.41 | 0.9483 | 6.98 | |||
P/E | 27.04 | 47.88 | 37.02 | |||
Ev/Ebitda | 18.68 | 12.9 | 21.86 | |||
Debt/Ebitda | 0.0301 | 5.54 | 0.1028 | |||
Efficiency | ||||||
ROE | 20.02 | 2.11 | 20.31 | |||
ROA | 16.84 | 0.9913 | 16.25 | |||
ROIC | 0 | 5.63 | 24.61 | |||
Ebitda margin | 40.26 | 20.51 | 37.3 | |||
Net margin | 29.29 | 3.38 | 23.78 | |||
Momentum | ||||||
1 week, price changes | +5.27 % | -0.0881 % | +2.21 % | |||
1 month, price changes | -9.85 % | +5.89 % | -0.8901 % | |||
3 months, price changes | +2.09 % | +9.65 % | -10.41 % | |||
6 months, price changes | -3.38 % | +8.91 % | -14.52 % | |||
1 year, price changes | +19.64 % | +3.33 % | -6.7 % | |||
3 years, price changes | +24.87 % | |||||
5 years, price changes | ||||||
10 years, price changes |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription